Literature DB >> 6155449

Isoelectric focusing and quantitative estimation of cerebrospinal fluid and serum IgG in idiopathic polyneuropathy.

P Livrea, G B Zimatore, I L Simone, M Trojano, V Lepore, V Ferrara, F A Lupo, D Pedone.   

Abstract

Isoelectric focusing and quantitative estimation of serum and CSF IgG were performed in 85 patients with idiopathic polyneuropathy (IP), subdivided according to the clinical course (acute, subacute, recurrent, chronic). Acute IP very frequently had an increase of oligoclonal and/or polyclonal serum IgG during the progressive phase and blood-CSF barrier damage accompanied by polyclonal IgG intrathecal synthesis during the stationary phase. Polyclonal IgG intrathecal synthesis was also present in several not acute IP and seemed to forecast unfavorable course. Oligoclonal IgG synthesis occurs very rarely within CSF but is a frequent finding in serum of patients with IP. Abnormalities of the IgG serum pattern are neither specific for any clinical course of IP nor of prognostic value. The possible significance of such findings is discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6155449     DOI: 10.1007/BF00313135

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  35 in total

1.  Isoelectric focusing of CSF proteins in neurological diseases.

Authors:  K G Kjellin; O Vesterberg
Journal:  J Neurol Sci       Date:  1974-10       Impact factor: 3.181

2.  Isoelectric focusing of proteins in polyacrylamide gels.

Authors:  O Vesterberg
Journal:  Biochim Biophys Acta       Date:  1972-01-26

3.  Serum immunoglobulin and complement (C3) levels: a study in adults with idiopathic, chronic polyneuropathies and motor neuron diseases.

Authors:  J N Whitaker; J Sciabbarrasi; W K Engel; J R Warmolts; W Strober
Journal:  Neurology       Date:  1973-11       Impact factor: 9.910

4.  Idiopathic polyneuritis (Landry-Guillain-Barré-Strohl syndrome) and experimental allergic neuritis: a comparison.

Authors:  B G Arnason
Journal:  Res Publ Assoc Res Nerv Ment Dis       Date:  1971

5.  Circulating demyelinating factors in acute idiopathic polyneuropathy.

Authors:  S D Cook; P C Dowling; M R Murray; J N Whitaker
Journal:  Arch Neurol       Date:  1971-02

6.  Serum-CSF protein gradients, the blood-GSF barrier and the local immune response.

Authors:  G Schliep; K Felgenhauer
Journal:  J Neurol       Date:  1978-05-18       Impact factor: 4.849

7.  Crossed immunoelectrofocusing of cerebrospinal fluid immunoglobulins.

Authors:  A Sidén
Journal:  J Neurol       Date:  1977-12-13       Impact factor: 4.849

8.  Biochemical findings in multiple sclerosis. II. A detailed study of the serum IgA, IgG and IgM levels of 772 MS patients compared with 226 neurological controls.

Authors:  P Delmotte; L Demonty
Journal:  J Neurol       Date:  1976-01-14       Impact factor: 4.849

9.  Guillain-Barré syndrome with slow progressive onset and persistent elevation of spinal fluid protein.

Authors:  R C Hinman; K R Magee
Journal:  Ann Intern Med       Date:  1967-11       Impact factor: 25.391

10.  Cerebrospinal fluid proteins in multiple sclerosis.

Authors:  G Lamoureux; R Jolicoeur; N Giard; M St-Hilaire; F Duplantis
Journal:  Neurology       Date:  1975-06       Impact factor: 9.910

View more
  3 in total

1.  Intrathecal IgG synthesis in multiple sclerosis: comparison between isoelectric focusing and quantitative estimation of cerebrospinal fluid IgG.

Authors:  P Livrea; M Trojano; I L Simone; G B Zimatore; G Lamontanara; R Leante
Journal:  J Neurol       Date:  1981       Impact factor: 4.849

2.  Clinical significance of serum and CSF findings in the Guillain-Barré syndrome and related disorders.

Authors:  O G Segurado; H Krüger; H G Mertens
Journal:  J Neurol       Date:  1986-08       Impact factor: 4.849

3.  Idiopathic inflammatory polyradiculoneuropathy: evaluation of clinical and laboratory data and therapeutic considerations.

Authors:  G Valli; L Ferini Strambi; E Nobile Orazio; G Scarlato
Journal:  Ital J Neurol Sci       Date:  1983-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.